Becton Dickinson Japan Enters Cervical Cytology Screening Business
This article was originally published in PharmAsia News
Executive SummaryBecton Dickinson Japan has started cervical cytology screening with the company's launch of the BD FocalPoint system in July. BD Japan also plans to market SurePath Pap test and PrepStain Slide Processor starting in January, when a license expires with Medical and Biologic Laboratories. MBL is currently marketing the two products in Japan. With a business focus on cervical cytology screening, BD Japan is strengthening marketing operations and plans to enter the prevention medical market. (Click here for more - Japanese language)
You may also be interested in...
Hiring travails, inspection pre-announcement, lack of translators highlighted in congressional hearing on FDA foreign inspections.
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.